xylazine has been researched along with Hypertrophy, Left Ventricular in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using a high-frequency linear transducer (15L8), we studied 1) the feasibility of performing echocardiography in nonanesthetized mice compared with mice given pentobarbital sodium (Pento) or a mixture of ketamine and xylazine and 2) the feasibility of echocardiographic evaluation of left ventricular (LV) hypertrophy, dilatation, and function in mice with two-kidney, one-clip hypertension or myocardial infarction (MI)." | 3.70 | Echocardiographic assessment of cardiac function in conscious and anesthetized mice. ( Carretero, OA; Kim, HE; Kurihara, N; Liu, YH; Rhaleb, NE; Yang, XP, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, XP | 1 |
| Liu, YH | 1 |
| Rhaleb, NE | 1 |
| Kurihara, N | 1 |
| Kim, HE | 1 |
| Carretero, OA | 1 |
1 other study available for xylazine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Echocardiographic assessment of cardiac function in conscious and anesthetized mice.
Topics: Adjuvants, Anesthesia; Anesthesia, General; Anesthetics, Dissociative; Animals; Drug Combinations; E | 1999 |